These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Response to: oesophageal adenocarcinoma and atrophic gastritis - different viewpoints on the junction. Bornschein J. Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):985-6. PubMed ID: 26114912 [No Abstract] [Full Text] [Related]
44. Role of obesity in Barrett's esophagus and cancer. Murray L, Romero Y. Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735 [Abstract] [Full Text] [Related]
54. Pathologic risk factors of adenocarcinoma of the gastric cardia and gastroesophageal junction. Carneiro F, Chaves P. Surg Oncol Clin N Am; 2006 Oct; 15(4):697-714. PubMed ID: 17030268 [Abstract] [Full Text] [Related]
55. [Epidemiology of adenocarcinomas of the esophagus and esophagogastric junction]. Robaszkiewicz M. Cancer Radiother; 2001 Nov; 5 Suppl 1():78s-79s. PubMed ID: 11797288 [No Abstract] [Full Text] [Related]
58. Short Barrett: prevalence and risk factors. de Mas CR, Krämer M, Seifert E, Rippin G, Vieth M, Stolte M. Scand J Gastroenterol; 1999 Nov; 34(11):1065-70. PubMed ID: 10582754 [Abstract] [Full Text] [Related]